Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia
Affiliations
Affiliations
- Naguy, MBBch, MSc, Child/Adolescent Psychiatrist, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, State of Kuwait. Al-Humoud, MD, MJ, FRCPC, Consultant Adult and Forensic Psychiatrist, Head of Forensic Psychiatry and General Adult Psychiatry Units , KCMH. Pridmore, MD, Professor of Psychiatry, University of Tasmania, Hobart, Australia. Y. Abuzeid, MD, PhD, Professor of Psychiatry, Ain Shams Institute of Psychiatry, Ain Shams Faculty of Medicine, Egypt, and Consultant Psychiatrist, KCMH, Kuwait. Singh, MBBch, MD, Mrcpsych (UK), Speciality Doctor, Learning Disabilities, Exeter, Devon NHS partnership Trust, UK, and Assistant Professor, Psychiatry, Saraswati medical college, Lucknow, India. Elsori, MD, ABP, Developmental Pediatrician, Rhode Island Hospital, Brown University, Providence, Rhode Island, United States.
25 February 2022
Abstract
Avoidant/Restrictive Food Intake Disorder and misophonia seem to be overrepresented in autism spectrum disorder. Literature is mute on psychopharmacotherapy in these complex presentations. Here, authors report on a challenging case of low-functioning ASD child with comorbid ARFID and misophonia that responded favorably to a low-dose risperidone. This is followed by a brief discussion of purported pharmacodynamic mechanisms and relevant literature.
Keywords: ARFID; ASD; misophonia; risperidone.
Similar articles
Dovey TM, Kumari V, Blissett J; Mealtime Hostage Parent Science Gang.Eur Psychiatry. 2019 Sep;61:56-62. doi: 10.1016/j.eurpsy.2019.06.008. Epub 2019 Jul 13.PMID: 31310945
Kozak A, Czepczor-Bernat K, Modrzejewska J, Modrzejewska A, Matusik E, Matusik P.Int J Environ Res Public Health. 2023 May 14;20(10):5822. doi: 10.3390/ijerph20105822.PMID: 37239549 Free PMC article.
Bertrand V, Dhenin C, Déchelotte P, Faerber M.Eat Weight Disord. 2022 Jun;27(5):1913-1918. doi: 10.1007/s40519-021-01315-0. Epub 2021 Oct 8.PMID: 34623607 Review.
Bourne L, Mandy W, Bryant-Waugh R.Dev Med Child Neurol. 2022 Jun;64(6):691-700. doi: 10.1111/dmcn.15139. Epub 2022 Feb 2.PMID: 35112345 Review.
Farag F, Sims A, Strudwick K, Carrasco J, Waters A, Ford V, Hopkins J, Whitlingum G, Absoud M, Kelly VB.Dev Med Child Neurol. 2022 Feb;64(2):176-182. doi: 10.1111/dmcn.14977. Epub 2021 Aug 17.PMID: 34405406
Cited by
MDMA for the treatment of misophonia, a proposal.
Webb J, Keane S.Front Psychiatry. 2022 Nov 10;13:983285. doi: 10.3389/fpsyt.2022.983285. eCollection 2022.PMID: 36440420 Free PMC article.
Agomelatine Monotherapy for Autism-A Case Report.
Naguy A, Pridmore S, Jamali MA, Hasan AE, Alamiri B.Psychopharmacol Bull. 2022 Oct 27;52(4):100-103.PMID: 36339272
Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field.
Ferrer-Torres A, Giménez-Llort L.Int J Environ Res Public Health. 2022 Jun 1;19(11):6790. doi: 10.3390/ijerph19116790.PMID: 35682372 Free PMC article. Review.